Evolution of Embolic Agents in Interventional Neuroradiology

Abstract

The growth in understanding of the pathophysiological relationships between various neurovascular diseases in the past decades has increased the significance and need for endovascular treatment. Consequently, an extraordinary development of different embolic agents was indispensable. The present work first presents the historical milestones in the discovery of various embolic materials used for neurovascular interventions. In the second part, the current endovascular embolization procedures, requiring both liquid and solid embolic agents, are discussed. In some cases and diseases the combination of both may be mandatory. Special emphasis is placed on the consideration needed when choosing appropriate embolic materials, chiefly depending on the goal of the endovascular procedure. Furthermore, the present understanding of the specifics in angioarchitecture and hemodynamics, leading to the most suitable form of access to the vascular lesion, will be covered. Regarding the latter, it is important to note that the aim should always be to achieve optimal superselectivity while being aware of all approaches, ranging from transarterial and transvenous to direct puncture. Finally, based on the limitations of the currently available embolic materials, we present a brief outlook on the future of new liquid and solid embolic agents.

Endovascular treatment of head and neck arteriovenous malformations: long-term angiographic and quality of life results

“…The endovascular procedure of our choice is primarily a transarterial superselective microcatheter-based approach followed by embolization using liquid embolic agents with different viscosities to achieve a casting of the whole nidus 10. Kühne and Helmke were among the first to recognize and use Ethibloc as an excellent liquid embolic agent for embolization of HNAVMs 11.…”

Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs

“…We prefer to use n-BCA in high-flow fistulous aferents 6. Its polymerization rate and visualization depend on the final concentration after mixing it with radiopaque ethiodized oil, a polymerization retardant 7. In very high-flow fistulas, additional 1–3 μm tantalum powder could be added in order to improve radiopacity and lower the concentration of ethiodized oil to ranges of 10–30%.…”

In vitro Implementation of Photopolymerizable Hydrogels as a Potential Treatment of Intracranial Aneurysms

“…Using liquid embolic agents to treat aneurysms is not a new concept (Brassel and Meila, 2015). They allow the whole volume of aneurysms of any shape or size to be filled.…”